EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton

Juan Sun, Ze-Yu Fang, Yi-Nuo Tao, Yi-Heng Zhang, Yao Zhang, Hai-Ya Sun, Yang Zhou, Yuan-Feng Wu

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202300146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Juan Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, 310023, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Protein Kinase Inhibitors, Quinazolinones. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Ningbo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Febrifugine is a kind of quinazolinone compound with high biological activity from a Chinese herb called Chang Shan ( Dichroa febrifuga ). Febrifugine and its derivatives possess extensive biological activities, some of which exhibited anti‐tumor activities as FAK inhibitors. However, they are not very effective at inhibiting tumor metastasis, perhaps because tumors gain energy through compensatory activation of other signaling pathways that promote cell migration and invasion. Therefore, seventeen novel febrifugine derivatives with quinazolinone skeleton were designed, synthesized and acted as potential FAK/PLK1 dual inhibitors. These compounds were determined by 1 H‐NMR, 13 C‐NMR and MS. Most of the compounds exhibited good inhibitory activity against cancer cell lines by computer‐assisted screening, antitumor activity test and FAK/PLK1 inhibitory activity test, wherein compound 3b was screened as a high‐efficiency lead compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsProtein Kinase InhibitorsQuinazolinonesCell LineCell ProliferationDrug DesignDrug Screening Assays, AntitumorMagnetic Resonance SpectroscopyMolecular Docking SimulationSkeletonStructure-Activity RelationshipFocal Adhesion Kinase 1Polo-Like Kinase 1PiperidinesQuinazolines

Stichwörter der Autor:innen

FAK/PLK1antitumorfebrifuginemolecular dockingquinazolinone

Substanzen

Antineoplastic AgentsProtein Kinase InhibitorsQuinazolinonesFocal Adhesion Kinase 1Polo-Like Kinase 1PTK2 protein, humanfebrifuginePiperidinesQuinazolines

Autor:innen und Institutionen

  • School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, 310023, P. R. China.
  • Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Ningbo

Zitieren

APA

Sun, J., Fang, Z. Y., Tao, Y. N., Zhang, Y. H., Zhang, Y., Sun, H. Y., Zhou, Y., & Wu, Y. F. (2023). Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300146

Vancouver

Sun J, Fang ZY, Tao YN, Zhang YH, Zhang Y, Sun HY, et al. Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300146

BibTeX
@article{Sun2023,
  author = {Sun, Juan and Fang, Ze-Yu and Tao, Yi-Nuo and Zhang, Yi-Heng and Zhang, Yao and Sun, Hai-Ya and Zhou, Yang and Wu, Yuan-Feng},
  title = {Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202300146}
}
Kostenlos starten →